Linked Life Data

1907708

Source:http://linkedlifedata.com/resource/pubmed/id/1907708

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1991-9-12
pubmed:abstractText
Using a Markov process to simulate and assess surveillance policies for stage I nonseminomatous germ cell tumors, the authors analyzed costs and effectiveness for the various policies that have been used clinically. They found no real differences in effectiveness, defined as probability of surviving two years, between the policies. There were significant differences in costs. The model is used to suggest schedules that might be more cost-effective than those currently employed. The model suggests that computed tomographic scanning of the abdomen may not be essential to the effectiveness of surveillance protocols.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0272-989X
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
131-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
The use of a Markov process to simulate and assess follow-up policies for patients with malignant disease: surveillance for stage I nonseminomatous tumors of the testis.
pubmed:affiliation
Princess Margaret Hospital, Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't